Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Grand House Mulia Tbk. (HOMI) vs UBC Medical Indonesia Tbk. (LABS)

Grand House Mulia Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Grand House Mulia Tbk. dan UBC Medical Indonesia Tbk.: Grand House Mulia Tbk. diperdagangkan di Rp198 (kapitalisasi pasar 303,98 M, volume 24 jam 8,9 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Grand House Mulia Tbk., dan Grand House Mulia Tbk. lebih aktif diperdagangkan (8,9 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.

HOMILABS
Kapitalisasi Pasar
303,98 M635,95 M
Volume
8,9 jt843 rb
Lot
89,02 rb8,43 rb
Perputaran
1,68 M137,6 jt
Harga Rata-rata
188,25163,22
Nilai Transaksi
1,68 M137,6 jt
Harga Ekuilibrium Indikatif
198165
Volume Ekuilibrium Indikatif
530246

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

HOMI
Lihat detail
LABS
Lihat detail

Tentang Grand House Mulia Tbk.

PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.

Selengkapnya di halaman HOMI

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS